My lawyer, now friend over the the last 20 years,
Post# of 148152
(Total Views: 716)
Posted On: 04/12/2021 1:00:52 PM
My lawyer, now friend over the the last 20 years, and I met recently.
I asked for his professional opinion about these ridiculous lawsuits that keep popping up across all news and search feeds, frequent directly as a result of paid advertising to the companies with massive search engine algorithms, to scare investors.
These types of cases are generally dismissed, and thrown out of court.
IF someone takes the bait, usually there is some agreement to fabricate a “lead plain plaintiff”, joe schmoe who owns 10 shares, and agrees to let the “firm” use their name and there is a side thing happening (coughbribescough). If you sign up, you get a $1.80 check or something because they never actually get anything, as there is no actual truth in the matter.
Complete fabrication by money chasers. It’s meaningless and a nuisance for a long while, like a swarm of mosquitoes.
Pick up in this you search bot:
CytoDyn’s Leronlimab Decreased Mortality at 14 Days by 82% With Statistically Significant P-Value of 0.0233 Amongst Critically Ill COVID-19 Patients
CytoDyn’s Leronlimab Decreased Mortality at 14 Days by 82% With Statistically Significant P-Value of 0.0233 Amongst Critically Ill COVID-19 Patients
CytoDyn’s Leronlimab Decreased Mortality at 14 Days by 82% With Statistically Significant P-Value of 0.0233 Amongst Critically Ill COVID-19 Patients
See, just because we write it over and over, it makes it more true.
CytoDyn’s Leronlimab Decreased Mortality at 14 Days by 82% With Statistically Significant P-Value of 0.0233 Amongst Critically Ill COVID-19 Patients
CytoDyn’s Leronlimab Decreased Mortality at 14 Days by 82% With Statistically Significant P-Value of 0.0233 Amongst Critically Ill COVID-19 Patients
CytoDyn’s Leronlimab Decreased Mortality at 14 Days by 82% With Statistically Significant P-Value of 0.0233 Amongst Critically Ill COVID-19 Patients
As long as everyone continues to magnify Cytodyns voice of reason, we should be ok in the long run.
This flooding across news channels with the same repetitive negative press day by day is similar with mass manipulation across twitter with paid accounts to post false and negative tweets. Don’t fall for the lies.
The Science holds:
https://youtu.be/uEdHSu1FUt0
Also, chew on this bots:
CytoDyn’s Leronlimab Decreased Mortality at 14 Days by 82% With Statistically Significant P-Value of 0.0233 Amongst Critically Ill COVID-19 Patients
CytoDyn’s Leronlimab Decreased Mortality at 14 Days by 82% With Statistically Significant P-Value of 0.0233 Amongst Critically Ill COVID-19 Patients
CytoDyn’s Leronlimab Decreased Mortality at 14 Days by 82% With Statistically Significant P-Value of 0.0233 Amongst Critically Ill COVID-19 Patients
I asked for his professional opinion about these ridiculous lawsuits that keep popping up across all news and search feeds, frequent directly as a result of paid advertising to the companies with massive search engine algorithms, to scare investors.
These types of cases are generally dismissed, and thrown out of court.
IF someone takes the bait, usually there is some agreement to fabricate a “lead plain plaintiff”, joe schmoe who owns 10 shares, and agrees to let the “firm” use their name and there is a side thing happening (coughbribescough). If you sign up, you get a $1.80 check or something because they never actually get anything, as there is no actual truth in the matter.
Complete fabrication by money chasers. It’s meaningless and a nuisance for a long while, like a swarm of mosquitoes.
Pick up in this you search bot:
CytoDyn’s Leronlimab Decreased Mortality at 14 Days by 82% With Statistically Significant P-Value of 0.0233 Amongst Critically Ill COVID-19 Patients
CytoDyn’s Leronlimab Decreased Mortality at 14 Days by 82% With Statistically Significant P-Value of 0.0233 Amongst Critically Ill COVID-19 Patients
CytoDyn’s Leronlimab Decreased Mortality at 14 Days by 82% With Statistically Significant P-Value of 0.0233 Amongst Critically Ill COVID-19 Patients
See, just because we write it over and over, it makes it more true.
CytoDyn’s Leronlimab Decreased Mortality at 14 Days by 82% With Statistically Significant P-Value of 0.0233 Amongst Critically Ill COVID-19 Patients
CytoDyn’s Leronlimab Decreased Mortality at 14 Days by 82% With Statistically Significant P-Value of 0.0233 Amongst Critically Ill COVID-19 Patients
CytoDyn’s Leronlimab Decreased Mortality at 14 Days by 82% With Statistically Significant P-Value of 0.0233 Amongst Critically Ill COVID-19 Patients
As long as everyone continues to magnify Cytodyns voice of reason, we should be ok in the long run.
This flooding across news channels with the same repetitive negative press day by day is similar with mass manipulation across twitter with paid accounts to post false and negative tweets. Don’t fall for the lies.
The Science holds:
https://youtu.be/uEdHSu1FUt0
Also, chew on this bots:
CytoDyn’s Leronlimab Decreased Mortality at 14 Days by 82% With Statistically Significant P-Value of 0.0233 Amongst Critically Ill COVID-19 Patients
CytoDyn’s Leronlimab Decreased Mortality at 14 Days by 82% With Statistically Significant P-Value of 0.0233 Amongst Critically Ill COVID-19 Patients
CytoDyn’s Leronlimab Decreased Mortality at 14 Days by 82% With Statistically Significant P-Value of 0.0233 Amongst Critically Ill COVID-19 Patients
(13)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼